Oppenheimer & Co’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
Other funds holding SBRA
CIM
Oppenheimer & Co's SBRA Position: Q2 2026 in Review
Oppenheimer & Co increased its Sabra Healthcare REIT (SBRA) stake by 8.4% in Q2 2026, buying an estimated $56.7K and bringing the position to 36,952 shares worth $721K. The position accounts for 0.01% of the portfolio, ranked #1088.
Oppenheimer & Co first reported a position in SBRA in Q3 2018 and has held it in 14 quarters since. The position peaked at $783K in Q3 2019. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- Oppenheimer & Co held 36,952 shares of Sabra Healthcare REIT worth $721K as of Q2 2026.
- Oppenheimer & Co bought 2,857 Sabra Healthcare REIT shares in Q2 2026, an estimated $56.7K.
- Sabra Healthcare REIT made up 0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1088 holding.
- Oppenheimer & Co first reported a position in Sabra Healthcare REIT in Q3 2018 and has held it in 14 quarters since.
- Oppenheimer & Co's Sabra Healthcare REIT position peaked at $783K in Q3 2019.
- 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.